MAJI.US Marijuana Inc.
- Market cap
- USD 268K
- P/E
- -
- P/B
- 203.08x
- ROE
- 99.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Apr 2026.
Is MAJI.US undervalued?
Graham numberThe Graham number of Marijuana Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Marijuana Inc. fundamental analysis
No fundamental analysis for Marijuana Inc. yet.
Marijuana Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Marijuana Inc.
Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.
Full company profileMarijuana Inc. financial statements
Marijuana Inc. annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | - | - | - | - | - | 28.8K | - | - | 500.00 |
| Gross Profit | - | -125K | -468K | -143.00 | -143.00 | -143.00 | 28.0K | -3.22K | - | -173K |
| Operating Income | -1.12K | -1.52K | -936K | -468K | -2.57K | -10.4K | -10.4K | -56.8K | -254K | -509K |
| EBITDA | 11.4K | - | -435K | 32.9K | -1.50K | 159K | -9.60K | -53.6K | - | -483K |
| Net Income | 11.4K | -575.00 | -125K | -436K | -1.64K | 158K | -5.14K | -56.8K | -320K | 13.5M |
| EPS | 0.00 | 0.00 | -0.01 | -0.03 | 0.00 | 0.01 | 0.00 | 0.00 | -0.01 | 0.33 |
| Balance Sheet | ||||||||||
| Total Assets | 2.47K | 1.59K | 58.3K | 58.3K | 810.00 | 2.42K | 2.00M | 1.36M | 203K | 14.4M |
| Total Liabilities | 276K | 90.7K | 214K | 445K | 161K | 4.17K | 49.3K | 53.3K | 519K | 787K |
| Shareholders' Equity | -274K | -89.1K | -214K | -387K | -160K | -1.76K | 1.96M | 1.31M | -316K | 13.6M |
| Cash & Short-term Investments | 2.47K | 1.59K | - | - | - | - | 65.0K | 5.00 | 100.00 | 14.4M |
| Total Debt | - | 7.70K | 7.71K | 247K | - | - | 52.4K | - | 412K | 261K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -1.52K | -884.00 | -9.30K | -170K | 286.00 | 286.00 | 4.25K | -22.5K | -49.6K | 13.9M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.25K | 2.00 | 0.00 | 3.00 |
| Free Cash Flow | -1.52K | -884.00 | -9.30K | -170K | 286.00 | 286.00 | 4.25K | -22.5K | -49.6K | 13.9M |
| Ratios | ||||||||||
| ROE | - | - | - | - | - | - | -0.3% | -4.3% | - | 99.6% |
| ROA | 460.3% | -36.2% | -214.5% | -748.3% | -202.8% | 6,552.8% | -0.3% | -4.2% | -158.0% | 94.1% |
| Net Profit Margin | - | - | - | - | - | - | -17.8% | - | - | 2,703,644.6% |
| Debt to Equity | - | - | - | - | - | - | 0.03x | - | - | 0.02x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Marijuana Inc. dividends
Marijuana Inc. has not paid dividends in the last 10 fiscal years.
Last stock split: 1:20 on Nov 15, 2022.
Who owns Marijuana Inc.
Ownership data of Marijuana Inc. is not available yet.
Marijuana Inc. company profile
- Company name
- Marijuana Inc.
- Ticker
- MAJI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 2
- Fiscal year end
- April
- Address
- 7901 4th Street N #23494, Saint Petersburg, FL, United States, 33702
- Phone
- 509 605 6533
- Website
- exousiapro.com
About Marijuana Inc.
Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.
Marijuana Inc. management
1- Mr. Donald J. SteinbergCEO & Director · born 1950